Joe Biden: I Know Firsthand the Toll of This Disease, Get Screened
FDA Approves Durvalumab Plus Enfortumab Vedotin for Muscle-Invasive Bladder Cancer
Belzutifan Plus Lenvatinib Moves Closer to EU Approval for Advanced Kidney Cancer
YOGI Aims to Create New Opportunities for Young GI Oncologists Across Europe - CancerWorld
One Procedure, Two Goals: Lung Biopsy and Cryoablation Show Promising Results in Early-Stage NSCLC
Anthropic CEO Dario Amodei: Can AI Cure Cancer by 2036?
CALR-Mutated MPN: A Shared Neoantigen Makes Immunotherapy Possible, and Antibodies Lead So Far
UICC Wins Best International Association Award at the Association Excellence Awards 2026 in London
OncoDaily RT is the dedicated radiation oncology platform of OncoDaily, focused on the rapidly evolving field of radiotherapy and cancer treatment. It covers clinical research, treatment advances, technology, education, and global collaboration, including precision radiotherapy, stereotactic radiotherapy, brachytherapy, adaptive radiotherapy, proton therapy, artificial intelligence, treatment toxicity, survivorship, patient-centered care, and integration with systemic treatments. Through OncoDaily RT, radiation oncologists, medical physicists, researchers, trainees, industry partners, and multidisciplinary cancer care professionals can follow the latest research, emerging technologies, treatment innovations, congress updates, expert perspectives, interviews, articles, social media coverage, and expert-led discussions, while sharing knowledge and advancing radiation oncology worldwide.
